Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain
Background. The objective of this simulation model was to assess the cost-effectiveness of different biological treatment strategies based on levels of disease activity in Spain, in patients with moderate to severe active RA and an insufficient response to at least one anti-TNF agent. Methods. Clini...
Main Authors: | Ariel Beresniak, Rafael Ariza-Ariza, Jose Francisco Garcia-Llorente, Antonio Ramirez-Arellano, Danielle Dupont |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | International Journal of Inflammation |
Online Access: | http://dx.doi.org/10.4061/2011/727634 |
Similar Items
-
Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014-07-01) -
The prevalence of rheumatoid arthritis in Spain
by: Lucía Silva-Fernández, et al.
Published: (2020-12-01) -
Cost-effectiveness of Biological Treatments in Patients with Rheumatoid Arthritis
by: Huey-Fen Chen, et al.
Published: (2011) -
Epidemiology, resource use and costs of rheumatoid arthritis in Argentina
by: Anastasia Secco, et al.
Published: (2020-09-01) -
Indirect costs of rheumatoid arthritis
by: Filip Raciborski, et al.
Published: (2015-12-01)